Alzheimer’s Society makes historic £50 million investment in the UK Dementia Research Institute
Alzheimer's Society are tackling dementia with a £50 million investment to establish the UK's first dedicated Dementia Research Institute.
A quarter of a billion pounds has been pledged towards the UK’s first ever Dementia Research Institute.
In partnership with the Medical Research Council and Alzheimer’s Research UK, the pledge marks one of the single biggest financial commitments to dementia research in the history of both charities.
Announced by the Prime Minister in his Challenge on Dementia 2020, the Institute has been backed by £150m of government investment. It will bring together scientists and experts from across the globe to transform the landscape of dementia research and firmly secure the UK’s reputation as a world leader in research and development against dementia.
Set to be fully up and running by 2020, the Institute will have a central UK hub with a network of regional centres and is expected to engage hundreds of researchers. Its focus will include the innovative, discovery science needed to unlock our understanding of the mechanisms underlying the development and progression of dementia. as well as research to improve care and public health strategies to reduce risk of dementia for future generations.
Alzheimer’s Society’s involvement, along with Alzheimer’s Research UK, will be essential in connecting the work of researchers and medical professionals with the experiences of people living with dementia. This will help to transform research findings into real changes for the diagnosis, treatment, care and prevention of dementia.
Universities and Science Minister Jo Johnson said: “This government has been crystal clear that we want Britain to lead the way in tackling this terrible condition, and scientific research and understanding is crucial to this.
“This Institute, with unprecedented funding from government and leading charities presents a unique opportunity for to pull together the UK’s world leading scientists and cutting edge research tools to get on with the job of defeating these diseases for good.”
Sir John Savill, Chief Executive of the Medical Research Council, said: “I’m grateful to Alzheimer’s Society for leadership in supporting an impactful and comprehensive research mission for the Institute and to Alzheimer’s Research UK for committing funds to the DRI that are additional to ground-breaking investments in Drug Discovery Institutes, which are well positioned to ensure translation of DRI discoveries into therapies.
“MRC is delighted to welcome both charities as co-founders of a partnership that we hope may attract further members in time. Together, we will lead the UK’s dementia research efforts, to search for new means to prevent and cure dementia and to transform the supportive care that people and families affected by established dementia receive. The UK Dementia Research Institute will be the research cornerstone in the fight against dementia.”
Jeremy Hughes CBE, Chief Executive of the Alzheimer’s Society, said: “The UK Dementia Research Institute heralds an exciting era for global dementia research as it launches an unprecedented collaboration of world-leading dementia expertise and provides the largest single investment in dementia research to date.
“Alzheimer’s Society is working to create a better world for those living with dementia and their families, and this significant investment emphasises how important research is in achieving our ambitions. Today we offer people affected by dementia, and all of us, hope for a better future in much the same way that cancer research has transformed how we diagnose, treat and care for those living with cancer.”
Hilary Evans, Chief Executive of Alzheimer’s Research UK, said: “Alzheimer’s Research UK’s £50m commitment to the UK Dementia Research Institute as a founding partner adds major impetus in our drive to deliver new dementia treatments. As the largest joint effort in dementia research the UK has ever seen, this commitment sends a strong signal that we are serious about taking the fight to the condition.
“Through world-leading research we can transform the lives of people with dementia, and our investment will help accelerate progress, as well as uniting the brightest scientific minds to focus on this great medical challenge. Alzheimer’s Research UK’s existing strategic initiatives, such as our Drug Discovery Alliance, will ensure promising breakthroughs made at the Institute are fed directly into the development of much-needed new treatments. The Institute, the power of the partnership around it and the potential it holds to transform UK research mark the next major step in our journey towards defeating dementia.”
The Medical Research Council will also be launching its search for an outstanding scientist to lead the Institute in the role of Director - expected to be an expert in the field and responsible for driving forward the world class research of the Institute.